Blocadren Related Clinical Trials
Timolol Option for Ulcerated Hemangiomas (TOUCH Trial) [Withdrawn]
Topical Timolol Benefit in Venous Ulcers [Not yet recruiting]
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG [Completed]
24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG [Completed]
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects [Completed]
24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination [Completed]
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% [Withdrawn]
Interaction Study of Timolol Eye Drops and Paroxetine Capsules [Completed]
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn [Recruiting]
The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter [Not yet recruiting]
Topical Timolol Gel for the Treatment of Infantile Hemangiomas [Not yet recruiting]
Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops [Completed]
24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol [Completed]
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas [Recruiting]
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States [Completed]
Topical Timolol for Superficial Infantile Hemangioma [Recruiting]
Comparison of Latanoprost Vs. Timolol [Completed]
Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations [Completed]
Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy [Completed]
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients [Completed]
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [Completed]
Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma [Recruiting]
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Active, not recruiting]
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Completed]
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Active, not recruiting]
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Active, not recruiting]
Topical Timolol for the Treatment of Benign Vascular Periocular Lesions [Withdrawn]
Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel [Recruiting]
Safety and Efficacy of Travoprost/Timolol BAC-free [Completed]
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension [Completed]
COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED) [Completed]
24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost [Completed]
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension [Recruiting]
The International Collaborative Exfoliation Syndrome Treatment Study [Active, not recruiting]
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Recruiting]
24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination [Completed]
Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma [Completed]
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs [Completed]
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Completed]
A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension [Completed]
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies [Completed]
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Completed]
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) [Completed]
Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial [Completed]
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]
VISION5 Product Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension [Completed]
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]
DE-111 Against Timolol Ophthalmic Solution 0.5% [Completed]
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients [Completed]
Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients [Recruiting]
24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice [Completed]
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy [Terminated]
A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma [Completed]
Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) [Completed]
Pupillary Response After Glaucoma Medication [Completed]
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [Completed]
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Completed]
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension [Completed]
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Completed]
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]
Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures [Completed]
A Double-masked Study of AR-13324 in Patients With Glaucoma and Ocular Hypertension [Active, not recruiting]
Adherence Assessment With Travalert Dosing Aid [Completed]
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide [Completed]
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Not yet recruiting]
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Completed]
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated [Completed]
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol [Completed]
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination [Completed]
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension [Completed]
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia [Completed]
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom [Completed]
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% [Completed]
A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients [Completed]
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension [Completed]
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. [Completed]
Bimatoprost/Timolol Versus Travoprost/Timolol [Completed]
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept [Recruiting]
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada [Completed]
AR-12286 in Combination With Latanoprost [Completed]
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Completed]
Adjunctive Study of AL-37807 Ophthalmic Suspension [Completed]
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure [Recruiting]
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (Rocket-3) [Recruiting]
Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea [Completed]
Dose-Ranging Study of the Bimatoprost Ocular Insert [Active, not recruiting]
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [Completed]
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [Completed]
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Completed]
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients [Terminated]
Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients [Not yet recruiting]
|
